AC Immune (ACIU) vs Sutro Biopharma, Inc. (STRO)
AC Immune and Sutro Biopharma, Inc. are both Biotechnology companies. AC Immune and Sutro Biopharma, Inc. are of similar size ($260.5M and $249.4M). Sutro Biopharma, Inc. grew revenue faster over the last twelve months: −56.3% against −85.6%. Sutro Biopharma, Inc. has the higher net margin (−395.3% vs −1,783.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Sutro Biopharma, Inc. leads on 10 and AC Immune on 4.
Valuation
Profitability
| Metric | ACIU | STRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (1,745.75%) | (319.57%) | 0.00% |
| Net margin | (1,783.66%) | (395.25%) | 0.00% |
| Free cash flow margin | 0.00% | (318.63%) | 0.00% |
| Return on equity | 0.00% | 266.76% | (57.72%) |
| Return on assets | 0.00% | (79.08%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack